Ambea AB (publ)

LSE:0RNX Stock Report

Market Cap: SEK 8.1b

Ambea Valuation

Is 0RNX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0RNX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0RNX (SEK96.55) is trading below our estimate of fair value (SEK311.06)

Significantly Below Fair Value: 0RNX is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0RNX?

Key metric: As 0RNX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0RNX. This is calculated by dividing 0RNX's market cap by their current earnings.
What is 0RNX's PE Ratio?
PE Ratio13.4x
EarningsSEK 604.00m
Market CapSEK 8.10b

Price to Earnings Ratio vs Peers

How does 0RNX's PE Ratio compare to its peers?

The above table shows the PE ratio for 0RNX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average28.9x
CVSG CVS Group
22.6x15.5%UK£592.6m
SPI Spire Healthcare Group
32.2x26.9%UK£912.6m
MDC Mediclinic International
21.9x10.7%UK£3.7b
AMS Advanced Medical Solutions Group
39x20.5%UK£434.4m
0RNX Ambea
13.4x11.5%SEK 8.1b

Price-To-Earnings vs Peers: 0RNX is good value based on its Price-To-Earnings Ratio (13.4x) compared to the peer average (31.3x).

Price to Earnings Ratio vs Industry

How does 0RNX's PE Ratio compare vs other companies in the European Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0RNX 13.4xIndustry Avg. 18.2xNo. of Companies8PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0RNX is good value based on its Price-To-Earnings Ratio (13.4x) compared to the European Healthcare industry average (18.2x).

Price to Earnings Ratio vs Fair Ratio

What is 0RNX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0RNX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.4x
Fair PE Ratio25.1x

Price-To-Earnings vs Fair Ratio: 0RNX is good value based on its Price-To-Earnings Ratio (13.4x) compared to the estimated Fair Price-To-Earnings Ratio (25.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0RNX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 96.55
SEK 115.33
+19.5%
5.7%SEK 120.00SEK 106.00n/a3
Dec ’25SEK 96.30
SEK 115.33
+19.8%
5.7%SEK 120.00SEK 106.00n/a3
Nov ’25SEK 90.31
SEK 106.00
+17.4%
5.3%SEK 110.00SEK 98.00n/a3
Oct ’25SEK 90.02
SEK 106.00
+17.8%
5.3%SEK 110.00SEK 98.00n/a3
Sep ’25SEK 91.70
SEK 106.00
+15.6%
5.3%SEK 110.00SEK 98.00n/a3
Aug ’25SEK 78.20
SEK 94.33
+20.6%
11.8%SEK 110.00SEK 85.00n/a3
Jul ’25SEK 78.90
SEK 89.33
+13.2%
12.8%SEK 105.00SEK 78.00n/a3
Jun ’25SEK 72.80
SEK 82.67
+13.6%
4.0%SEK 85.00SEK 78.00n/a3
May ’25SEK 62.45
SEK 79.67
+27.6%
4.8%SEK 85.00SEK 76.00n/a3
Apr ’25SEK 63.75
SEK 79.67
+25.0%
4.8%SEK 85.00SEK 76.00n/a3
Mar ’25SEK 62.44
SEK 78.00
+24.9%
6.5%SEK 85.00SEK 73.00n/a3
Feb ’25SEK 52.15
SEK 70.67
+35.5%
5.9%SEK 75.00SEK 65.00n/a3
Jan ’25SEK 52.74
SEK 63.33
+20.1%
13.0%SEK 75.00SEK 57.00n/a3
Dec ’24SEK 44.48
SEK 63.33
+42.4%
13.0%SEK 75.00SEK 57.00SEK 96.303
Nov ’24SEK 41.46
SEK 57.33
+38.3%
15.7%SEK 70.00SEK 50.00SEK 90.313
Oct ’24SEK 35.01
SEK 61.75
+76.4%
17.7%SEK 75.00SEK 50.00SEK 90.024
Sep ’24SEK 38.50
SEK 61.75
+60.4%
17.7%SEK 75.00SEK 50.00SEK 91.704
Aug ’24SEK 34.02
SEK 61.25
+80.0%
18.6%SEK 75.00SEK 50.00SEK 78.204
Jul ’24SEK 35.17
SEK 62.50
+77.7%
16.5%SEK 75.00SEK 50.00SEK 78.904
Jun ’24SEK 34.46
SEK 62.50
+81.4%
16.5%SEK 75.00SEK 50.00SEK 72.804
May ’24SEK 38.92
SEK 60.88
+56.4%
19.3%SEK 75.00SEK 48.50SEK 62.454
Apr ’24SEK 36.09
SEK 60.88
+68.7%
19.3%SEK 75.00SEK 48.50SEK 63.754
Mar ’24SEK 35.48
SEK 62.13
+75.1%
20.7%SEK 75.00SEK 48.50SEK 62.444
Feb ’24SEK 40.01
SEK 66.75
+66.8%
14.1%SEK 75.00SEK 52.00SEK 52.154
Jan ’24SEK 44.61
SEK 77.00
+72.6%
10.0%SEK 90.00SEK 70.00SEK 52.744
Dec ’23SEK 50.93
SEK 77.00
+51.2%
10.0%SEK 90.00SEK 70.00SEK 44.484

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 03:15
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ambea AB (publ) is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Erik MobergBerenberg
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Karl NorénDanske Bank